Regeneron to launch Phase 3 trials of antibody 'cocktail' for COVID-19

Drugmaker Regeneron announced plans Monday to begin Phase 3 clinical trials of a " double antibody cocktail " for use as a possible treatment for COVID-19.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news